Low molecular weight contaminants in commercial preparations of plasmin and t-PA activate neurons

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 12, 2008, Pages 2218-2220

  Samson, A L ^a   Nevin, S T ^b   Medcalf, Robert L ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; N METHYL DEXTRO ASPARTIC ACID; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR;

ANALYTIC METHOD; CALCIUM TRANSPORT; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTAMINATION; CONTROLLED STUDY; LETTER; MOLECULAR WEIGHT; NERVE CELL; NERVE CELL NECROSIS; NERVE STIMULATION; PHARMACOLOGICAL BLOCKING; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNAPTIC TRANSMISSION;

ANIMALS; CELLS, CULTURED; DIALYSIS; DRUG CONTAMINATION; MICE; MOLECULAR WEIGHT; NEURONS; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 56749158175     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03174.x     Document Type: Letter

References (12)

1. Samson AL, Medcalf RL. Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 2006; 50: 673-8.
2. Strickland S. Tissue plasminogen activator in nervous system function and dysfunction. Thromb Haemost 2001; 86: 138-43.
3. Tsirka SE, Gualandris A, Amaral DG, Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995; 377: 340-4.
4. Chen ZL, Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91: 917-25.
5. Fredriksson L, Li H, Fieber C, Li X, Eriksson U. Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J 2004; 23: 3793-802.
6. Rogove AD, Siao C, Keyt B, Strickland S, Tsirka SE. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci 1999; 112: 4007-16.
7. Medina MG, Ledesma MD, Dominguez JE, Medina M, Zafra D, Alameda F, Dotti CG, Navarro P. Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J 2005; 24: 1706-16.
8. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997; 17: 543-52.
9. Samson AL, Nevin ST, Croucher D, Niego B, Weiss TW, Moreno E, Monard D, Lawrence DA, Medcalf RL Tissue-type plasminogen activator requires a co-receptor to enhance N-Methyl-D-Aspartate receptor function. J Neurochem 2008; 107: 1091-4.
10. Mizutani A, Tanaka T, Saito H, Matsuki N. Postsynaptic blockade of inhibitory postsynaptic currents by plasmin in CA1 pyramidal cells of rat hippocampus. Brain Res 1997; 761: 93-6.
11. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002; 5: 405-14.
12. Oh HS, Kwon OW, Chung I, Lee SC, Koh HJ, Lee SH, Lee JH. Retinal toxicity of commercial tissue plasminogen activator is mediated by the induction of nitric oxide in the mouse retinal primary cells. Curr Eye Res 2005; 30: 291-7.